Click to view your profile
Click to search for condition or expert
Click to open main menu
Acute Myeloid Leukemia (AML) Latest Advances
Find the Latest Research About Acute Myeloid Leukemia (AML)
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 02/19/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 744 publications
See more filters
Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid Leukemia.
Condition:
Acute Myeloid Leukemia (AML)
Journal:
Hematology/oncology and stem cell therapy
Treatment Used:
Chimeric Antigen Receptor (CAR) T-Cell Therapy
Number of Patients:
0
Published:
December 20, 2022
VIEW PUBLICATION
SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid Leukemia.
Condition:
Acute Myeloid Leukemia (AML)
Journal:
Clinical lymphoma, myeloma & leukemia
Treatment Used:
Maintenance Therapy
Number of Patients:
0
Published:
December 01, 2022
VIEW PUBLICATION
An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial).
Condition:
Acute Promyelocytic Leukemia (APL)
Journal:
Blood cancer journal
Treatment Used:
All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO) vs. All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO) Plus Chemotherapy (CHT)
Number of Patients:
128
Published:
November 20, 2022
VIEW PUBLICATION
Impact of posttransplant cyclophosphamide on the outcome of patients undergoing unrelated single-unit umbilical cord blood transplantation for pediatric acute leukemia.
Condition:
Pediatric Acute Leukemia
Journal:
BMC cancer
Treatment Used:
Posttransplant Cyclophosphamide (PTCY)
Number of Patients:
52
Published:
November 19, 2022
VIEW PUBLICATION
Current status and future perspective of CAR T-cell therapy for acute myeloid leukemia.
Condition:
Acute Myeloid Leukemia (AML)
Journal:
[Rinsho ketsueki] The Japanese journal of clinical hematology
Treatment Used:
CAR T-Cell Therapy
Number of Patients:
0
Published:
November 09, 2022
VIEW PUBLICATION
Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: An Overview of Systematic Reviews.
Condition:
Acute Myeloid Leukemia (AML)
Journal:
International journal of clinical practice
Treatment Used:
Hematopoietic Stem Cell Transplantation (HSCT)
Number of Patients:
0
Published:
October 24, 2022
VIEW PUBLICATION
Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia.
Condition:
High-Risk Acute Promyelocytic Leukemia (APL)
Journal:
Journal of hematology & oncology
Treatment Used:
Oral Arsenic and Retinoic Acid
Number of Patients:
54
Published:
October 18, 2022
VIEW PUBLICATION
Updated treatment strategies for myelodysplastic syndromes.
Condition:
Myelodysplastic Syndromes (MDS)
Journal:
[Rinsho ketsueki] The Japanese journal of clinical hematology
Treatment Used:
Hematopoietic Cell Transplantation, Erythropoiesis-Stimulating Agents, and Oral Iron Chelators
Number of Patients:
0
Published:
October 02, 2022
VIEW PUBLICATION
Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Acute Promyelocytic Leukemia.
Condition:
Relapsed Acute Promyelocytic Leukemia (APL)
Journal:
Transplantation and cellular therapy
Treatment Used:
Allogeneic Hematopoietic Cell Transplantation (HCT)
Number of Patients:
195
Published:
September 30, 2022
VIEW PUBLICATION
AML-389 Phase 1/2 Study of SEL24/MEN1703, a First-in-Class Dual PIM/FLT3 Kinase Inhibitor, in Patients With IDH1/2-Mutated Acute Myeloid Leukemia: The DIAMOND-01 Trial.
Condition:
IDH1/2-Mutated Acute Myeloid Leukemia (AML)
Journal:
Clinical lymphoma, myeloma & leukemia
Treatment Used:
SEL24/MEN1703, Dual PIM/FLT3 Kinase Inhibitor
Number of Patients:
20
Published:
September 27, 2022
VIEW PUBLICATION
AML-484 First Results of a Phase II Study (STIMULUS-AML1) Investigating Sabatolimab + Azacitidine + Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia (ND AML).
Condition:
Newly Diagnosed Acute Myeloid Leukemia (AML)
Journal:
Clinical lymphoma, myeloma & leukemia
Treatment Used:
Sabatolimab Plus Azacitadine Plus Ventoclax
Number of Patients:
18
Published:
September 27, 2022
VIEW PUBLICATION
AML-262 Pivekimab Sunirine (PVEK, IMGN632) Triplet With Azacitidine and Venetoclax Shows Broad Activity in Adverse Genetic Subsets of Relapsed/Refractory Acute Myeloid Leukemia and Reduced Infusion-Related Reactions.
Condition:
Relapsed/Refractory Acute Myeloid Leukemia (AML)
Journal:
Clinical lymphoma, myeloma & leukemia
Treatment Used:
Pivekimab Sunirine (PVEK) Triplet with Azacitidine and Venetoclax
Number of Patients:
29
Published:
September 27, 2022
VIEW PUBLICATION
Showing 1-12 of 744
Next
Last Updated: 02/19/2023